Skip to main content

It looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.

Switch to US ($)
Contact +33 (0)3 90 20 54 70

📢 ProteoGenix Loyalty Program is live — Earn points on every online order. Discover the program

Get 25% off your first bioreagent online order — use code: PROTEOSHOP25
Brand: ProteoGenix

Crenezumab Biosimilar – Anti-APP Abeta42 and Abeta40 mAb – Research Grade

Clonality:
Monoclonal Antibody
Isotype:
IgG4, Kappa

€200.00

100ug + 200 loyalty points
Size
Clear
  • In Stock
  • Free shipping in EU on orders > €500
  • Wide range of unique reagents
  • Fast worldwide delivery
Crenezumab Biosimilar - Anti-APP Abeta42 and Abeta40 mAb - Research Grade

Crenezumab Biosimilar - Anti-APP Abeta42 and Abeta40 mAb - Research Grade

Product name Crenezumab Biosimilar - Anti-APP Abeta42 and Abeta40 mAb - Research Grade
Source CAS 1095207-05-8
Species Humanized
Expression system Mammalian cells
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB
Aliases /Synonyms Crenezumab,MABT5102A,RG7412,APP Abeta42 and Abeta40,anti-APP Abeta42 and Abeta40
Reference PX-TA1269
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG4-kappa
Clonality Monoclonal Antibody
Product name Crenezumab Biosimilar - Anti-APP Abeta42 and Abeta40 mAb - Research Grade
Source CAS 1095207-05-8
Species Humanized
Expression system Mammalian cells
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB,,,
Aliases /Synonyms Crenezumab,MABT5102A,RG7412,APP Abeta42 and Abeta40,anti-APP Abeta42 and Abeta40
Reference PX-TA1269
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG4-kappa
Clonality Monoclonal Antibody

General information on Anti-APP Abeta42 and Abeta40[Homo sapiens] (Crenezumab) Monoclonal Antibody

Crenezumab has been investigated for the treatment of Alzheimer’s Disease.

There are no reviews yet.

Be the first to review “Crenezumab Biosimilar – Anti-APP Abeta42 and Abeta40 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Recently viewed products

Loading recently viewed products…

Can’t find what you need?

Our catalog doesn’t cover everything — but our team does. Whether you need a custom antibody, a specific protein variant, or a bulk order, our scientists are here to help.

Contact Our Team Book a Call

Cart (0 Items)

Your cart is currently empty.

View Products